Literature DB >> 2875271

Effect of high tonic levels of luteinising hormone on outcome of in-vitro fertilisation.

C M Howles, M C Macnamee, R G Edwards, R Goswamy, P C Steptoe.   

Abstract

Mesh：

Substances：

Year:  1986        PMID： 2875271     DOI： 10.1016/s0140-6736(86)90395-8

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  19 in total

Review 1.  In vitro fertilization treatment in patients with polycystic ovaries.

Authors:  A Shulman; J Dor
Journal:  J Assist Reprod Genet       Date:  1997-01       Impact factor: 3.412

Review 2.  The significance of high follicular-phase luteinizing hormone levels in the treatment of women with polycystic ovarian syndrome by in vitro fertilization.

Authors:  B C Tarlatzis; G Grimbizis
Journal:  J Assist Reprod Genet       Date:  1997-01       Impact factor: 3.412

3.  Successful treatment of infertility due to polycystic ovary disease using a combination of luteinising hormone releasing hormone agonist and low dosage menotrophin.

Authors:  M Armitage; T Wilkin; K Dewbury
Journal:  Br Med J (Clin Res Ed)       Date:  1987-07-11

4.  Relative bioactivity of endogenous luteinizing hormone during superovulation therapy for in vitro fertilization in normal-cycling women.

Authors:  M I Abuzeid; J K Hodges; C R Harlow; M G Hull
Journal:  J Assist Reprod Genet       Date:  1996-09       Impact factor: 3.412

Review 5.  Low- versus high-dose human menopausal gonadotropin in an in vitro fertilization-embryo transfer program.

Authors:  T Levy; Z Ben-Rafael
Journal:  J Assist Reprod Genet       Date:  1995-04       Impact factor: 3.412

Review 6.  Polycystic ovarian disease (PCOD)--pregnancy rate and outcome in in vitro fertilization.

Authors:  D Bider; D Levran; S Mashiach; I Ben-Shlomo; J Dor
Journal:  J Assist Reprod Genet       Date:  1993-01       Impact factor: 3.412

7.  What is the best protocol for ovarian superovulation?

Authors:  B Hedon; B Camier; F Arnal; C Humeau
Journal:  J Assist Reprod Genet       Date:  1993-10       Impact factor: 3.412

8.  Efficacy of low-dose human chorionic gonadotropin (hCG) in a GnRH antagonist protocol.

Authors:  Kyono Koichi; Nakajo Yukiko; Kumagai Shima; Sasaki Sachiko
Journal:  J Assist Reprod Genet       Date:  2006-06-20       Impact factor: 3.412

9.  The clinical ramifications of polycystic ovarian morphology in oocyte donors.

Authors:  M Cho; G Ambartsumyan; H Danzer; K Brennan; M Surrey
Journal:  J Assist Reprod Genet       Date:  2013-01-05       Impact factor: 3.412

10.  Improvement of in vitro fertilisation after treatment with buserelin, an agonist of luteinising hormone releasing hormone.

Authors:  A J Rutherford; R J Subak-Sharpe; K J Dawson; R A Margara; S Franks; R M Winston
Journal:  Br Med J (Clin Res Ed)       Date:  1988-06-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.